Results 151 to 160 of about 160,518 (194)

Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA). [PDF]

open access: yesSyst Rev
Nwankwo L   +9 more
europepmc   +1 more source

Allergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes

open access: yesSeminars in Respiratory and Critical Care Medicine, 2011
While allergic bronchopulmonary aspergillosis (ABPA) is well recognized as a fungal complication of asthma, severe asthma with fungal sensitization (SAFS) is not.
David W. Denning
exaly   +2 more sources

Allergic bronchopulmonary aspergillosis [PDF]

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2005
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated lung disease which occurs predominantly in patients with asthma, and is caused by hypersensitivity to colonized Aspergillus fumigatus. It is a chronic, relapsing disorder which can clinically range from mild asthma to fibrotic lung disease.
A -B Tonnel
exaly   +5 more sources

Allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology, 1984
Allergic bronchopulmonary aspergillosis (ABPA) complicates asthma and cystic fibrosis. The survival factors in Aspergillus fumigatus that support saprophytic growth in bronchial mucus are not understood. Prednisone remains the most definitive treatment but need not be administered indefinitely.
A J, Ricketti   +3 more
openaire   +6 more sources

Home - About - Disclaimer - Privacy